0001127602-12-003243.txt : 20120131
0001127602-12-003243.hdr.sgml : 20120131
20120131204111
ACCESSION NUMBER: 0001127602-12-003243
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20120127
FILED AS OF DATE: 20120131
DATE AS OF CHANGE: 20120131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BEIER DAVID W
CENTRAL INDEX KEY: 0001187054
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 12560755
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0304
4
2012-01-27
0000318154
AMGEN INC
AMGN
0001187054
BEIER DAVID W
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
SVP, Global Govt Affairs
Common Stock
2012-01-27
4
M
0
17500
58.61
A
49402
D
Common Stock
2012-01-27
4
M
0
30000
42.13
A
79402
D
Common Stock
2012-01-27
4
M
0
10000
50.44
A
89402
D
Common Stock
2012-01-27
4
S
0
57500
68.4679
D
31902
D
Nqso (Right to Buy)
58.61
2012-01-27
4
M
0
17500
0
D
2006-03-15
2012-03-15
Common Stock
17500
0
D
Nqso (Right to Buy)
42.13
2012-01-27
4
M
0
30000
0
D
2009-04-29
2015-04-29
Common Stock
30000
10000
D
Nqso (Right to Buy)
50.44
2012-01-27
4
M
0
10000
0
D
2010-04-28
2016-04-28
Common Stock
10000
30000
D
The price reported is an average price. The prices ranged from $68.38 to $68.495 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 7,500 RSUs which vest in two equal installments of 2,475 each on 4/25/2013 and 4/25/2014 and one installment of 2,550 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
/s/ Andrea A. Robinson, Attorney-in-Fact for Mr. Beier
2012-01-31
EX-24
2
doc1.txt
POA
Exhibit 24
Power of Attorney
Know all men by these presents, that the undersigned hereby
constitutes and appoints each of John C. Ayres, Andrea A. Robinson and
Richard T. Benson, signing singly, the undersigneds true and lawful
attorney-in-fact to execute for and on behalf of the undersigned Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended, and the rules thereunder, as may be required as a result
of the undersigneds position as an officer and/or director of Amgen Inc.
(the Company).
The undersigned hereby grants to each such attorney-in-fact
full power and authority to execute such Forms 3, 4 and 5 as fully to all
intents and purposes as the undersigned might or could do if personally
present, with full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such attorney-in-facts
substitute or substitutes, shall lawfully do or cause to be done by virtue
of this power of attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigneds
responsibilities to comply with Section 16 of the Securities Exchange Act
of 1934, as amended.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4
and 5 with respect to the undersigneds holdings of and transactions
in securities issued by the Company, unless earlier revoked by the
undersigned in a signed writing delivered to the foregoing attorneys-
in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 19th day of October, 2011.
/s/ David W. Beier
Name: David W. Beier